amfAR, The Foundation for AIDS Research

amfAR Applauds Decision by U.S. Supreme Court to Uphold Majority of Health Care Reform Law

Ruling will help U.S. advance National HIV/AIDS Strategy; advocacy at state level critical for realization of full Medicaid expansion

For Immediate Release
Media Contact:
Cub Barrett, Program Communications Manager
(212) 806-1602 

NEW YORK, June 28, 2012—amfAR, The Foundation for AIDS Research on Thursday applauded the decision by the U.S. Supreme Court to uphold major portions of the Affordable Care Act (ACA), which will improve access to health care for thousands of Americans living with HIV/AIDS and advance progress toward achieving National HIV/AIDS Strategy goals.

“Today the Supreme Court announced a decision that will bring us closer to achieving the goals of the National HIV/AIDS Strategy, including providing access to treatment for thousands of people living with HIV who are not receiving this lifesaving care,” said amfAR CEO Kevin Robert Frost. “By expanding coverage and banning the denial of coverage based on pre-existing conditions, many thousands more people will have access to essential HIV prevention and treatment services.”

According to the White House, fewer than one in five American (17 percent) living with HIV/AIDS have private insurance, and nearly 30 percent do not have any coverage. The National HIV/AIDS Strategy, unveiled in 2010, calls for expanded access to treatment for people living with HIV and broader delivery of prevention and testing services to those who are especially vulnerable to HIV infection.

“Health reform is the game changer in this epidemic,” said amfAR Vice President and Director of Public Policy Chris Collins. “Now it is critical that all state governments embrace federal funding that will expand their Medicaid programs, ensuring that lower-income people in the U.S. have access to the care they need.”

About amfAR 

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of sound AIDS-related public policy. Since 1985, amfAR has invested more than $366 million in its programs and has awarded grants to more than 2,000 research teams worldwide.